NMUR2 and breast carcinoma: Other studies confirmed that NMU promotes a motile phenotype and showed its growth-inhibitory effect in NMUR2-positive (SKBR3) but not NMUR2-negative (Hs578T) breast cancer cells, indicating the importance of NMUR2-related signalling [34].